INFLAZYME PHARMACEUTICALS

inflazyme-pharmaceuticals-logo

Inflazyme Pharmaceuticals develops new drug therapies to improve the quality of life for patients suffering from chronic inflammatory diseases and auto-immune diseases.

#SimilarOrganizations #Financial #Website #More

INFLAZYME PHARMACEUTICALS

Industry:
Biotechnology Medical Pharmaceutical

Address:
Richmond, British Columbia, Canada

Country:
Canada

Website Url:
http://www.inflazyme.com

Total Employee:
1+

Status:
Active

Contact:
(604) 279-8511

Email Addresses:
[email protected]

Technology used in webpage:
Apache PHP Google Adsense Apache 2.2 Debian Debian Squeeze


Similar Organizations

calistoga-pharmaceuticals-logo

Calistoga Pharmaceuticals

Calistoga Pharmaceuticals develops therapeutic oral medicines for patients suffering from cancer and inflammatory diseases.

osprey-pharmaceuticals-usa-logo

Osprey Pharmaceuticals USA

Osprey Pharmaceuticals USA develops novel protein therapeutics for the treatment of inflammatory and immune diseases.

Acquisitions List

Date Company Article Price
2004-04-07 Adprotech Adprotech acquired by Inflazyme Pharmaceuticals N/A
2003-04-09 GlycoDesign GlycoDesign acquired by Inflazyme Pharmaceuticals N/A

Official Site Inspections

http://www.inflazyme.com

  • Host name: premium80-2.web-hosting.com
  • IP address: 199.188.200.236
  • Location: Los Angeles United States
  • Latitude: 34.0318
  • Longitude: -118.4252
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90064

Loading ...

More informations about "Inflazyme Pharmaceuticals"

Inflazyme Pharmaceuticals - Crunchbase Company Profile & Funding

Inflazyme Pharmaceuticals is located in Richmond, British Columbia, Canada. Who are Inflazyme Pharmaceuticals 's competitors? Alternatives and possible competitors to Inflazyme …See details»

Inflazyme Pharmaceuticals Ltd., Richmond, British Columbia

Inflazyme initiated Phase I human clinical trials with IPL576,092 in June 1999. The Company expects to receive interim results of its Phase I studies during Fall 1999 and final Phase I …See details»

Inflazyme Pharmaceuticals Ltd - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Inflazyme Pharmaceuticals Ltd of Richmond, BC. Get the latest business insights from Dun & Bradstreet.See details»

Inflazyme Pharmaceuticals - Drug pipelines, Patents, Clinical

Explore Inflazyme Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 1 literature, Technology Platform:Recombinant protein, Drug:Mirococept, GD …See details»

Inflazyme Pharmaceuticals Ltd. Information - RocketReach

Inflazyme Pharmaceuticals Ltd. is a development stage biopharmaceutical company focused on the discovery, development and commercialization of new therapies to treat inflammatory …See details»

Inflazyme Pharmaceuticals Ltd. - VentureRadar

Similar Companies: Protein Polymer Technologies Inc. (PPTI) USA n/a n/a Ardena Belgium n/a Ardena is a fully integrated Contract Development & Manufacturing Organization (CDMO) with …See details»

Inflazyme Pharmaceuticals - Crunchbase

Inflazyme Pharmaceuticals develops new drug therapies to improve the quality of life for patients suffering from inflammatory diseases.See details»

InflaZyme - Crunchbase Company Profile & Funding

Organization. InflaZyme . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Alternatives and possible competitors to InflaZyme may …See details»

InflaZyme - Drug pipelines, Patents, Clinical trials - Synapse

Explore InflaZyme with its drug pipeline, therapeutic area, technology platform, .See details»

Nextsource | Company Profile | Inflazyme Pharmaceuticals

Track key decision-makers at Inflazyme Pharmaceuticals who are attending upcoming industry events. Discover if Inflazyme Pharmaceuticals is expanding into new markets or launching …See details»

Inflazyme Pharmaceuticals - Products, Competitors, Financials ...

Inflazyme, Hoechst Marion Roussel to Develop Asthma/Allergy Drugs. Jan 6, 2018. Inflazyme Pharmaceuticals Ltd. (Richmond, BC, Canada) and Hoechst Marion Roussel (Kansas City, …See details»

Inflazyme Pharmaceuticals (Research & Development assets)

Who are Inflazyme Pharmaceuticals (Research & Development assets)’s investors? EACOM Timber has invested in Inflazyme Pharmaceuticals (Research & Development assets). When …See details»

Articles about Inflazyme Pharmaceuticals Ltd. - BioSpace

Sep 24, 2007 About Inflazyme Pharmaceuticals Ltd. Inflazyme Pharmaceuticals Ltd. is a biopharmaceutical company engaged in the discovery, development and commercialization of …See details»

Inflazyme Pharmaceuticals - Funding, Financials, Valuation

Apr 7, 2004 Inflazyme Pharmaceuticals has acquired 2 organizations. Their most recent acquisition was Adprotech on Apr 7, 2004. Acquisitions. ... Their most recent acquisition was …See details»

Inflazyme to sell assets to Swedish firm - The Toronto Star

Sep 24, 2007 VANCOUVER – Struggling drug developer Inflazyme Pharmaceuticals Ltd. (TSX: IZP ) has agreed to sell most of its assets to Sweden's Biolipox AB for up to $11 million plus …See details»

Business Profile for Inflazyme Pharmaceuticals Inc - Better …

This organization is not BBB accredited. Industrial Manufacturers in Vancouver, BC. See BBB rating, reviews, complaints, & more.See details»

Inflazyme, Hoechst Marion Roussel to Develop Asthma/Allergy …

May 18, 1999 Inflazyme expects to enter Phase I clinical trials with IPL576,092 in the UK before the end of June. IPL576,092 is Inflazyme's lead clinical candidate from its IPL576 class of …See details»

Inflazyme Pharmaceuticals (Inflazyme Pharmaceuticals) - 药物管 …

了解Inflazyme Pharmaceuticals (Inflazyme Pharmaceuticals)公司的药物管线,治疗领域,技术平台,以及它的1项临床试和1篇文献,技术平台:重组蛋白,药物:Mirococept,GD-4040,V …See details»

Inflazyme Pharmaceuticals - CB Insights

Explore {Inflazyme Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Inflazyme …See details»

Roche buys Inflazome as pharma interest in targeting …

Sep 21, 2020 Dive Brief: Swiss drugmaker Roche has agreed to pay 380 million euros, or about $447 million, for Dublin and Cambridge, U.K.-based biotech startup Inflazome.; The deal gives …See details»

linkstock.net © 2022. All rights reserved